Drugs / EMLA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02266160 | Nov 2014 → Nov 2015 | tinnitus | HaEmek Medical Center, Israel | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02266160 ↗ |
| Known as | EMLA cream 5% | “Drug: EMLA cream 5%” NCT02266160 ↗ |
| Route | Topical | “topical anaesthetics” NCT02266160 ↗ |